Spherix Incorporated , an intellectual property company, owns, develops, acquires, and monetizes patented and unpatented intellectual properties. The company owns approximately 290 patents and patent applications. Its patent portfolio includes the U.S. and foreign patents and pending patent applications in the wireless communications and telecommunication sectors, including data, optical and voice technology, antenna technology, Wi-Fi, base station functionality, and cellular. Spherix Incorporated was founded in 1967 and is based in New York, New York.

  • United States Patent & Trademark Office Allows Patent Claims for CBM BioPharma, Inc.'s Patent Application for Pancreatic Cancer Treatment
    on June 26, 2019 at 12:00 pm

    CBM Bolsters Intellectual Property Asset Portfolio NEW YORK , June 26, 2019 /PRNewswire/ -- CBM BioPharma Inc. ("CBM") today announced that the United States Patent & Trademark Office (USPTO) ... […]

  • Spherix Files Preliminary Proxy Statement Advancing the Planned Acquisition of Assets of CBM BioPharma, Inc.
    on June 19, 2019 at 12:00 pm

    NEW YORK, June 19, 2019 /PRNewswire/ -- Spherix Incorporated (SPEX) today announced that it has filed a Preliminary Proxy Statement with the Securities and Exchange Commission and announced a Special Meeting of Stockholders related to approving various items related to the proposed and previously announced acquisition of substantially all of the assets of CBM BioPharma, Inc. ("CBM"). The acquisition of the CBM assets constitutes another step in Spherix's continued transformation into an innovative pharmaceutical company with pioneering drugs and treatments focused on the development and commercialization of oncology therapeutics. CBM is a privately held pharmaceutical company with exclusive drug development rights from world renowned partners like Wake Forest University and University of Texas. […]

  • Spherix Inc. (NasdaqCM: SPEX) Trading Below Book Value; Diversified Asset Base Adds Value
    on June 11, 2019 at 2:10 pm

    MIAMI BEACH, FL / ACCESSWIRE / June 11, 2019 / Emerging stocks rarely provide more than a single compelling reason for investment. Having completed a recapitalization in May of 2019 that leaves SPEX with just over two million shares outstanding, the company's strategy to identify and invest in cutting-edge technology is already proving to be a profitable business model for SPEX. […]

  • StockLab Reports: By the Numbers
    on June 6, 2019 at 1:00 pm

    LAS VEGAS, NV / ACCESSWIRE / June 6, 2019 / In October of last year, StockLab's editorial team was introduced to Spherix Incorporated (SPEX). Frankly, it's tough to top a Spherix acquisition target restoring mobility to a nearly paralyzed rodent but last week's quarterly report perhaps rivals the moving mouse insofar as financial statements go. The Company has total assets of $11,937,000. […]

  • Spherix Reports First Quarter 2019 Results of $11,937,000 in Assets and $982,000 in Liabilities
    on May 16, 2019 at 12:00 pm

    Agreement to Acquire Assets of CBM BioPharma, Inc. In addition, the Company announced that it purchased a 20% shareholder's stake in CBM along with certain interests in DatChat, Inc. Spherix was successful in acquiring these interests in CBM at a substantial discount to CBM's valuation.  The 20% shareholder stake in CBM will give Spherix the ability to participate in any dividends declared by CBM in the future. […]

  • SmallCap Sentinel: One-on-One with Spherix CEO, Anthony Hayes
    on April 10, 2019 at 11:00 am

    ORLANDO, FL / ACCESSWIRE / April 10, 2019 / In today's issue of SmalCap Sentinel, we get the opportunity to virtually sit down with Spherix Incorporated (SPEX) CEO, Anthony Hayes. It has been an eventful year for Hayes and Spherix, much of which Hayes covered in a wide-ranging recent shareholderletter. […]

  • Emerging Markets Report: By Any Measure
    on April 3, 2019 at 3:40 pm

    ORLANDO, FL / ACCESSWIRE / April 3, 2019 / By any measure, Spherix Incorporated (NASDAQ: SPEX) has had a very good year. It is not often one can say at their annual meeting that the Company posted a one-time gain of $7.5 million and p.s., our science looks like it restored mobility to a mouse paralyzed by Acute Lymphoblastic Leukemia. With Spherix now booking total assets of $13.3 million, less than 9 million shares outstanding and zero debt, CEO Anthony Hayes has likely engendered some goodwill from his shareholder base. […]

  • Spherix Issues Letter to Shareholders
    on April 2, 2019 at 12:00 pm

    One of the most challenging tasks as CEO is taking the vision of the Board and transferring that into meaningful value for our shareholders.  However, 2018 marked a pivotal year for our Company as we forged ahead with the vision of creating an exciting biotechnology company.  With more than $13,000,000 in assets and less than 9,000,000 in outstanding shares, we are moving Spherix in the right direction. The CBM transaction, announced in October of last year, brings to Spherix exclusive drug development rights from world-renowned partners including Wake Forest Innovations and the University of Texas at Austin.  Significant progress has already been made. […]

  • SmallCap Sentinel: A Gain of Uncommon Proportions
    on March 13, 2019 at 3:20 pm

    ORLANDO, FL / ACCESSWIRE / March 13, 2019 / In the world of smaller equities, revenue, especially for emerging biotech or tech companies, can be fleeting, rare even. As such, Spherix Incorporated (SPEX) posting a one-time gain of $7.5 million in its 10-K should turn a few heads. It is notable that the $7.5 million one-time gain comes from an investment the Company and Spherex CEO Anthony Hayes made two years ago, putting $670k into a then private biotech called Hoth Therapeutics where Hayes saw potential and promise. […]

  • Spherix Announces Filing of its Annual Report on Form 10-K, Records $7.5 Million One Time Gain
    on March 12, 2019 at 12:00 pm

    NEW YORK , March 12, 2019 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX)- a technology development company committed to the fostering of innovative ideas, announced today that it has filed its Annual ... […]

    Feed has no items.

FULL NAME*

What's Your Role?*

WORK EMAIL*

COMPANY NAME*

Company Description*

HOW'D YOU HEAR ABOUT US?

DETAILS ABOUT YOUR GOALS

Spherix Incorporated

One Rockefeller Plaza
11th Floor
New York, NY 10020

+1 (703) 992-9325

www.spherix.com

July 2019
S M T W T F S
« Apr    
 123456
78910111213
14151617181920
21222324252627
28293031  

©2019 ALIGNMT LLC | Alignment Consulting | Mergers & Acquisitions | Investor Relations

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Log in with your credentials

or    

Forgot your details?

Create Account